Cargando…
Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach
A brain tumor (BT) is a condition in which there is growth or uncontrolled development of the brain cells, which usually goes unrecognized or is diagnosed at the later stages. Since the mechanism behind BT is not clear, and the various physiological conditions are difficult to diagnose, the success...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320031/ https://www.ncbi.nlm.nih.gov/pubmed/35889532 http://dx.doi.org/10.3390/molecules27144663 |
_version_ | 1784755694133575680 |
---|---|
author | Karthika, Chenmala Najda, Agnieszka Klepacka, Joanna Zehravi, Mehrukh Akter, Rokeya Akhtar, Muhammad Furqan Saleem, Ammara Al-Shaeri, Majed Mondal, Banani Ashraf, Ghulam Md. Tagde, Priti Ramproshad, Sarker Ahmad, Zubair Khan, Farhat S. Rahman, Md. Habibur |
author_facet | Karthika, Chenmala Najda, Agnieszka Klepacka, Joanna Zehravi, Mehrukh Akter, Rokeya Akhtar, Muhammad Furqan Saleem, Ammara Al-Shaeri, Majed Mondal, Banani Ashraf, Ghulam Md. Tagde, Priti Ramproshad, Sarker Ahmad, Zubair Khan, Farhat S. Rahman, Md. Habibur |
author_sort | Karthika, Chenmala |
collection | PubMed |
description | A brain tumor (BT) is a condition in which there is growth or uncontrolled development of the brain cells, which usually goes unrecognized or is diagnosed at the later stages. Since the mechanism behind BT is not clear, and the various physiological conditions are difficult to diagnose, the success rate of BT is not very high. This is the central issue faced during drug development and clinical trials with almost all types of neurodegenerative disorders. In the first part of this review, we focus on the concept of brain tumors, their barriers, and the types of delivery possible to target the brain cells. Although various treatment methods are available, they all have side effects or toxic effects. Hence, in the second part, a correlation was made between the use of resveratrol, a potent antioxidant, and its advantages for brain diseases. The relationship between brain disease and the blood–brain barrier, multi-drug resistance, and the use of nanomedicine for treating brain disorders is also mentioned. In short, a hypothetical concept is given with a background investigation into the use of combination therapy with resveratrol as an active ingredient, the possible drug delivery, and its formulation-based approach. |
format | Online Article Text |
id | pubmed-9320031 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93200312022-07-27 Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach Karthika, Chenmala Najda, Agnieszka Klepacka, Joanna Zehravi, Mehrukh Akter, Rokeya Akhtar, Muhammad Furqan Saleem, Ammara Al-Shaeri, Majed Mondal, Banani Ashraf, Ghulam Md. Tagde, Priti Ramproshad, Sarker Ahmad, Zubair Khan, Farhat S. Rahman, Md. Habibur Molecules Review A brain tumor (BT) is a condition in which there is growth or uncontrolled development of the brain cells, which usually goes unrecognized or is diagnosed at the later stages. Since the mechanism behind BT is not clear, and the various physiological conditions are difficult to diagnose, the success rate of BT is not very high. This is the central issue faced during drug development and clinical trials with almost all types of neurodegenerative disorders. In the first part of this review, we focus on the concept of brain tumors, their barriers, and the types of delivery possible to target the brain cells. Although various treatment methods are available, they all have side effects or toxic effects. Hence, in the second part, a correlation was made between the use of resveratrol, a potent antioxidant, and its advantages for brain diseases. The relationship between brain disease and the blood–brain barrier, multi-drug resistance, and the use of nanomedicine for treating brain disorders is also mentioned. In short, a hypothetical concept is given with a background investigation into the use of combination therapy with resveratrol as an active ingredient, the possible drug delivery, and its formulation-based approach. MDPI 2022-07-21 /pmc/articles/PMC9320031/ /pubmed/35889532 http://dx.doi.org/10.3390/molecules27144663 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Karthika, Chenmala Najda, Agnieszka Klepacka, Joanna Zehravi, Mehrukh Akter, Rokeya Akhtar, Muhammad Furqan Saleem, Ammara Al-Shaeri, Majed Mondal, Banani Ashraf, Ghulam Md. Tagde, Priti Ramproshad, Sarker Ahmad, Zubair Khan, Farhat S. Rahman, Md. Habibur Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach |
title | Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach |
title_full | Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach |
title_fullStr | Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach |
title_full_unstemmed | Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach |
title_short | Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach |
title_sort | involvement of resveratrol against brain cancer: a combination strategy with a pharmaceutical approach |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320031/ https://www.ncbi.nlm.nih.gov/pubmed/35889532 http://dx.doi.org/10.3390/molecules27144663 |
work_keys_str_mv | AT karthikachenmala involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach AT najdaagnieszka involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach AT klepackajoanna involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach AT zehravimehrukh involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach AT akterrokeya involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach AT akhtarmuhammadfurqan involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach AT saleemammara involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach AT alshaerimajed involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach AT mondalbanani involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach AT ashrafghulammd involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach AT tagdepriti involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach AT ramproshadsarker involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach AT ahmadzubair involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach AT khanfarhats involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach AT rahmanmdhabibur involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach |